adamantane has been researched along with u 100480 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, S; Dubuisson, T; Einck, L; Jakubiec, W; Ladukto, L; Nacy, CA; Reddy, VM; Wallis, RS | 1 |
| Campbell, S; Jakubiec, W; Ladutko, L; Miller, PF; Mitton-Fry, M; Paige, D; Silvia, A; Wallis, RS | 1 |
| Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW | 1 |
| Cole, ST; Dhar, N; Hartkoorn, RC; Lechartier, B; Sala, C; Vocat, A; Zhang, M | 1 |
1 review(s) available for adamantane and u 100480
| Article | Year |
|---|---|
Novel drugs against tuberculosis: a clinician's perspective.
Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2015 |
3 other study(ies) available for adamantane and u 100480
| Article | Year |
|---|---|
SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
Topics: Adamantane; Animals; Antitubercular Agents; Cell Line; Drug Interactions; Ethylenediamines; Macrophages; Mice; Microbial Viability; Mycobacterium tuberculosis; Oxazolidinones | 2012 |
Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Monitoring; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Time Factors | 2012 |
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
Topics: Adamantane; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Drug Discovery; Ethylenediamines; Genes, Bacterial; Luminescence; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Photorhabdus; Pyrazinamide; Rifamycins; Xanthenes | 2015 |